Accupril (Quinapril HCl Tablets) 40 mg, 90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Par...
FDA Recall #D-0874-2022 — Class II — April 22, 2022
Product Description
Accupril (Quinapril HCl Tablets) 40 mg, 90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017
Reason for Recall
CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
Recalling Firm
Pfizer Inc. — New York, NY
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
8346 bottles
Distribution
Nationwide and Puerto Rico
Code Information
Lots: DX6031 Exp. MAR 31 2023; CK6260 Exp. MAY 31 2022
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.